Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Asian Phytoceuticals Public Co. Ltd. (APCO.BK)
Lamphun, TH
Asian Phytoceuticals Public Company Limited engages in the research and development, manufacture, and distribution of healthcare and natural extracts-based beauty products in Thailand. The company offers cream and lotion products in bottles and tubes for massage to tighten the skin and reduce the desired area, and facial lotion products; and products for reverse aging, anti-aging, and longevity. It is also involved in the research on mangosteen under the project name Operation BIM. It also exports its products. The company was formerly known as Natural Cosmetics Research Co., Ltd. and changed its name to Asian Phytoceuticals Public Company Limited in July 2005. Asian Phytoceuticals Public Company Limited was founded in 1988 and is headquartered in Lamphun, Thailand.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.77% | +0.77% | -0.76% | -6.43% | -10.27% | -8.39% | -21.56% | -49.62% | -31.05% | -62.78% | +162.71% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%-5.1% Q1'26: +3.6% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%+1.3% Q1'26: +46.5% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+22.2% Q1'26: +34.0% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+26.8% ★ Q1'26: +29.0% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+20.1% ★ Q1'26: +22.9% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+0.0% Q1'26: -4.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×0.21× ★ Q1'26: 0.13× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
409.25M
est: 398.50M (+2.7%)
|
421.38M
est: 421.20M (+0.0%)
|
415.74M
est: 425.00M (-2.2%)
|
369.83M
est: 411.00M (-10.0%)
|
247.65M
est: 319.00M (-22.4%)
|
247.73M
est: 400.00M (-38.1%)
|
210.83M
est: 398.50M (-47.1%)
|
200.17M
est: 421.20M (-52.5%)
|
425.00M
425.00M – 425.00M
+0.9% YoY
|
411.00M
411.00M – 411.00M
-3.3% YoY
|
319.00M
319.00M – 319.00M
-22.4% YoY
|
400.00M
400.00M – 400.00M
+25.4% YoY
|
| EBITDA |
141.04M
est: 181.69M (-22.4%)
|
181.78M
est: 192.04M (-5.3%)
|
145.57M
est: 193.77M (-24.9%)
|
130.54M
est: 187.39M (-30.3%)
|
78.50M
est: 145.44M (-46.0%)
|
106.78M
est: 182.37M (-41.5%)
|
88.58M
est: 176.49M (-49.8%)
|
73.22M
est: 186.54M (-60.7%)
|
188.23M
188.23M – 188.23M
+0.9% YoY
|
182.03M
182.03M – 182.03M
-3.3% YoY
|
141.28M
141.28M – 141.28M
-22.4% YoY
|
177.15M
177.15M – 177.15M
+25.4% YoY
|
| EBIT |
119.14M
est: 140.77M (-15.4%)
|
131.43M
est: 148.79M (-11.7%)
|
122.77M
est: 150.13M (-18.2%)
|
110.14M
est: 145.19M (-24.1%)
|
65.58M
est: 112.69M (-41.8%)
|
75.53M
est: 141.30M (-46.5%)
|
67.90M
est: 137.80M (-50.7%)
|
53.58M
est: 145.65M (-63.2%)
|
146.97M
146.97M – 146.97M
+0.9% YoY
|
142.13M
142.13M – 142.13M
-3.3% YoY
|
110.31M
110.31M – 110.31M
-22.4% YoY
|
138.32M
138.32M – 138.32M
+25.4% YoY
|
| Net Income |
100.62M
est: 97.23M (+3.5%)
|
131.42M
est: 120.00M (+9.5%)
|
108.21M
est: 90.00M (+20.2%)
|
94.75M
est: 102.00M (-7.1%)
|
57.90M
est: 72.00M (-19.6%)
|
69.98M
est: 90.00M (-22.2%)
|
54.71M
est: 97.23M (-43.7%)
|
55.41M
est: 120.00M (-53.8%)
|
90.00M
90.00M – 90.00M
-25.0% YoY
|
102.00M
102.00M – 102.00M
+13.3% YoY
|
72.00M
72.00M – 72.00M
-29.4% YoY
|
90.00M
90.00M – 90.00M
+25.0% YoY
|
| SGA |
225.15M
est: 193.13M (+16.6%)
|
230.35M
est: 204.13M (+12.8%)
|
225.49M
est: 205.97M (+9.5%)
|
194.80M
est: 199.19M (-2.2%)
|
130.96M
est: 154.60M (-15.3%)
|
124.73M
est: 193.86M (-35.7%)
|
120.10M
est: 197.08M (-39.1%)
|
110.71M
est: 208.31M (-46.9%)
|
210.19M
210.19M – 210.19M
+0.9% YoY
|
203.27M
203.27M – 203.27M
-3.3% YoY
|
157.77M
157.77M – 157.77M
-22.4% YoY
|
197.82M
197.82M – 197.82M
+25.4% YoY
|
| EPS |
0.20
est: 0.16 (+23.4%)
|
0.25
est: 0.20 (+25.0%)
|
0.18
est: 0.15 (+20.0%)
|
0.16
est: 0.17 (-5.9%)
|
0.10
est: 0.12 (-19.6%)
|
0.12
est: 0.15 (-20.0%)
|
0.09
est: 0.16 (-43.7%)
|
0.09
est: 0.20 (-53.8%)
|
0.15
0.15 – 0.15
-25.0% YoY
|
0.17
0.17 – 0.17
+13.3% YoY
|
0.12
0.12 – 0.12
-29.4% YoY
|
0.15
0.15 – 0.15
+25.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jingjai Hanchanlash | Executive Director | 153.8K | — |
| Apinya Ulumpanon | Chief Financial Officer | — | female |
| Associate Arunee Wiriyachitra | President of Corporate Sustainability, Company Secretary & Executive Director | — | — |
| Jareerat Jintana | Chief Accountant | — | female |
| Ornphimol Prasertwit | Assistant to Chief Executive Officer of Marketing | — | female |
| Pichaet Wiriyachitra | Chief Executive Officer, MD & Director | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for APCO.BK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
